Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Challenges and future prospects on 3D in-vitro modeling of the neuromuscular circuit

dc.contributor.authorBadiola Mateos, Maider
dc.contributor.authorHervera Abad, Arnau
dc.contributor.authorRío Fernández, José Antonio del
dc.contributor.authorSamitier i Martí, Josep
dc.date.accessioned2019-08-26T11:01:11Z
dc.date.available2019-08-26T11:01:11Z
dc.date.issued2018-12-11
dc.date.updated2019-08-26T11:01:11Z
dc.description.abstractMovement of skeletal-muscle fibers is generated by the coordinated action of several cells taking part within the locomotion circuit (motoneurons, sensory-neurons, Schwann cells, astrocytes, microglia, and muscle-cells). Failure s in any part of this circuit could impede or hinder coordinated muscle movement and cause a neu romuscular disease (NMD) or determine its severity. Studying fragments of the circuit cannot provide a comprehensive and complete view of the pathological process. We trace the historic developments of studies focused on in-vitro modeling of the spinal-locomotion circuit and how bioengineered innovative technologies show advantages for an accurate mimicking of hysiological conditions of spinal-locomotion circuit. New developments on compartmentalized microfluidic culture systems (cμFCS), the use of human induced pluripotent stem cells (hiPSCs) and 3D cell-cultures are analyzed. We finally address limitations of current study models and three main challenges on neuromuscular studies: (i) mimic the whole spinal-locomotion circuit including all cell-types involved and the evaluation of independent and interdependent roles of each one; (ii) mimic the neurodegenerative response of mature neurons in-vitro as it occurs in-vivo ; and (iii) develop, tune, implement, and combine cμFCS, hiPSC, and 3D-culture technologies to ultimately create patient-specific complete, translational, and reliable NMD in-vitro model. Overcoming these challenges would significantly facilitate understanding the events taking place in NMDs and accelerate the process of finding new therapies.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec685893
dc.identifier.issn2296-4185
dc.identifier.pmid30622944
dc.identifier.urihttps://hdl.handle.net/2445/138717
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3389/fbioe.2018.00194
dc.relation.ispartofFrontiers in Bioengineering and Biotechnology, 2018, vol. 6, num. 194
dc.relation.urihttps://doi.org/10.3389/fbioe.2018.00194
dc.rightscc-by (c) Badiola Mateos, Maider et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Enginyeria Electrònica i Biomèdica)
dc.subject.classificationMalalties neuromusculars
dc.subject.classificationAparell locomotor
dc.subject.classificationBioenginyeria
dc.subject.otherNeuromuscular diseases
dc.subject.otherMusculoskeletal system
dc.subject.otherBioengineering
dc.titleChallenges and future prospects on 3D in-vitro modeling of the neuromuscular circuit
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
685893.pdf
Mida:
841.21 KB
Format:
Adobe Portable Document Format